background
although
public
health
guidelin
implic
resourc
alloc
issu
explicitli
consid
previou
pandem
prepared
respons
guidanc
order
ensur
thorough
inform
revis
guidanc
follow
pandem
systemat
review
publish
unpublish
econom
evalu
prepared
strategi
intervent
influenza
pandem
conduct
search
perform
septemb
use
electron
databas
internet
search
engin
refer
list
screen
cite
refer
search
direct
commun
relev
author
full
partial
econom
evalu
consid
cost
outcom
includ
convers
review
editori
studi
econom
impact
complic
exclud
studi
select
independ
review
result
studi
includ
although
compli
cost
effect
guidelin
qualiti
evid
limit
howev
data
sourc
use
higher
qualiti
econom
evalu
conduct
pandem
vaccin
drug
regimen
vari
pharmaceut
plu
nonpharmaceut
intervent
rel
cost
effect
comparison
vaccin
andor
antivir
alon
pharmaceut
intervent
vari
cost
save
high
cost
effect
ratio
accord
ceil
threshold
gross
nation
incom
per
capita
reduct
nonessenti
contact
use
pharmaceut
prophylaxi
plu
closur
school
amongst
cost
effect
strategi
countri
howev
quarantin
household
contact
cost
effect
even
low
middl
incom
countri
new
subtyp
influenza
viru
infecti
human
gain
humantohuman
transmiss
effici
enough
caus
commun
level
outbreak
viru
said
pandem
potenti
new
subtyp
spread
global
caus
diseas
death
becom
pandem
sinc
centuri
influenza
pandem
occur
interv
rang
year
creat
vari
level
impact
societi
march
new
subtyp
influenza
viru
identifi
mexico
unit
state
spread
contin
less
nine
week
becom
first
pandem
centuri
children
young
adult
pregnant
women
chronic
ill
disproportion
affect
constitut
major
hospit
case
estim
case
fatal
rate
death
middleag
adult
underli
diseas
although
concret
evid
macroeconom
consequ
pandem
yet
reveal
previou
studi
estim
potenti
reduct
labor
product
consumpt
demand
result
show
approxim
decreas
annual
gross
product
world
health
organ
publish
pandem
prepared
respons
guidanc
two
revis
first
second
document
summar
recommend
nation
action
pandem
influenza
accord
recogn
pandem
phase
recommend
evid
limit
observ
epidemiolog
model
case
infer
drawn
respiratori
infecti
diseas
season
influenza
sever
acut
respiratori
syndrom
view
incorpor
import
experi
evid
acquir
pandem
revis
pandem
prepared
guidelin
includ
cost
effect
evid
revis
process
strengthen
guidanc
provid
framework
priorit
alloc
limit
resourc
impend
high
risk
time
aim
paper
systemat
review
publish
unpublish
econom
evalu
intervent
control
prevent
human
influenza
pandem
fund
studi
describ
assess
identifi
studi
determin
pattern
cost
util
ratio
find
expect
contribut
revis
guidanc
pandem
influenza
potenti
support
policymak
make
inform
decis
alloc
resourc
effect
identifi
gap
futur
research
focus
nonpharmaceut
issu
also
cover
confer
proceed
also
perform
retriev
addit
grey
literatur
report
confer
proceed
search
expand
use
gener
search
engin
googl
wwwgooglecouk
scienc
specif
search
engin
sciru
wwwsciruscom
furthermor
refer
list
relev
public
screen
cite
refer
search
first
econom
evalu
topic
also
perform
use
web
scienc
via
isi
web
knowledg
addit
report
obtain
correspond
one
review
rpv
author
elig
studi
confer
abstract
search
strategi
use
control
vocabulari
thesauru
term
whenev
avail
relev
free
text
term
includ
pandem
influenza
cost
benefit
cost
cost
effect
econom
differ
combin
free
text
term
languag
also
employ
appropri
search
strategi
appli
electron
data
sourc
output
shown
tabl
identifi
abstract
review
two
independ
review
review
team
kw
np
rpv
sk
discrep
resolv
third
review
yt
paper
includ
analysi
met
criteria
shown
tabl
standard
data
extract
form
devis
articl
group
accord
type
evalu
follow
cost
minim
analysi
compar
cost
differ
intervent
evid
equal
effect
ii
cost
benefit
analysi
cba
measur
health
outcom
monetari
unit
iii
cost
effect
analysi
cea
express
health
outcom
natur
unit
eg
case
avert
hospit
avert
death
avert
iv
cost
util
analysi
cua
present
health
outcom
common
unit
eg
qualiti
adjust
life
year
qali
disabl
adjust
life
year
dali
studi
apprais
two
differ
way
qualiti
assess
purpos
follow
approach
employ
teerawattananon
et
al
first
assess
accord
specif
methodolog
report
practic
econom
evalu
studi
express
perspect
use
relationship
time
horizon
discount
report
increment
cost
effect
ratio
icer
perform
uncertainti
analysi
declar
fund
support
second
studi
assess
accord
qualiti
evid
use
sinc
wide
recogn
credibl
econom
evalu
depend
appropri
method
employ
also
input
evid
sever
type
evid
evalu
accord
level
qualiti
clinic
effect
size
ii
advers
event
complic
iii
baselin
clinic
data
iv
resourc
use
v
cost
vi
util
applic
cost
util
analys
data
sourc
compon
rank
one
six
descend
order
rank
given
paramet
deriv
appropri
data
sourc
detail
inform
rank
consult
tabl
technic
term
use
data
extract
definit
given
hta
glossari
use
http
htaglossarynet
review
compar
valu
money
differ
intervent
prevent
control
influenza
pandem
comparison
intervent
howev
evalu
conduct
differ
set
timefram
studi
convert
cost
effect
ratio
common
currenc
util
unit
cost
intern
dollar
valu
calcul
use
nation
gross
domest
product
deflat
valu
impli
purchas
power
pariti
convers
rate
intern
monetari
fund
http
wwwimf
orgexternalnscsaspx
id
addit
exchang
rate
obtain
oanda
websit
http
wwwoandacom
currencyhistoricalr
appli
cost
outcom
report
foreign
currenc
rather
local
equival
lack
explicit
implicit
threshold
countri
determin
intervent
cost
effect
world
bank
threshold
classifi
countri
low
incom
lower
middl
incom
upper
middl
incom
high
incom
countri
accord
gross
nation
incom
gni
per
capita
use
maximum
ceil
threshold
word
intervent
spent
fewer
resourc
upper
bound
gni
per
capita
given
world
bank
order
gain
one
qali
save
one
dali
repres
good
valu
money
search
electron
databas
identifi
total
record
addit
record
identifi
internet
search
engin
record
met
inclus
criteria
assess
elig
full
text
includ
final
analysi
studi
exclud
review
econom
evalu
focus
season
influenza
focus
impact
influenza
full
text
avail
confer
abstract
elig
languag
report
cost
outcom
intervent
addit
eight
full
text
paper
identifi
correspond
author
elig
paper
cite
refer
search
refer
list
screen
six
exclud
studi
impact
diseas
econom
evalu
final
studi
consid
analysi
figur
major
studi
adopt
cea
cua
approach
cea
cua
cea
cba
combin
cea
cua
combin
six
studi
report
cba
result
five
partial
econom
evalu
figur
illustr
relationship
among
studi
set
year
studi
year
public
half
studi
n
conduct
pandem
event
studi
assess
valu
money
intervent
unit
state
follow
canada
n
unit
kingdom
singapor
n
australia
netherland
franc
n
anoth
five
countri
one
studi
three
studi
conduct
tabl
inclus
exclus
criteria
employ
abstract
select
process
norigin
econom
evalu
consid
prevent
control
human
influenza
pandem
potenti
human
influenza
pandem
npartial
econom
evalu
cost
outcom
one
intervent
either
pharmaceut
nonpharmaceut
consid
nfull
econom
evalu
cost
outcom
one
pharmaceut
nonpharmaceut
intervent
consid
multin
set
exampl
one
conduct
three
european
countri
anoth
cover
ten
countri
divers
incom
group
characterist
studi
includ
analysi
summar
tabl
modifi
world
bank
classif
contain
mitig
influenza
pandem
tabl
depict
vaccin
n
antivir
drug
n
commonli
evalu
target
group
specif
group
high
risk
prioriti
popul
gener
popul
notabl
econom
evalu
assess
econom
valu
public
hygien
disinfect
measur
consider
discrep
among
drug
vaccin
regimen
consid
econom
evalu
although
major
n
assess
oseltamivir
use
differ
dosag
durat
prophylaxi
exampl
author
use
oseltamivir
mg
daili
day
prophylaxi
young
adult
us
whilst
other
use
dosag
oseltamivir
day
prophylaxi
among
isra
gener
popul
number
vaccin
dose
rang
one
three
vast
major
paper
clearli
specifi
durat
protect
tabl
tabl
show
extent
review
paper
compli
standard
conduct
report
econom
evalu
rel
high
proport
studi
describ
studi
perspect
select
compar
use
discount
cost
andor
outcom
studi
time
horizon
longer
one
year
perform
uncertainti
analys
howev
approxim
studi
calcul
report
icer
disclos
fund
sourc
twenti
eight
studi
adopt
societ
viewpoint
analysi
seven
studi
employ
healthcar
provid
perspect
four
studi
adopt
healthcar
system
perspect
regard
financi
support
studi
support
domest
public
funder
forprofit
privat
sector
public
privat
cofund
notforprofit
domest
intern
cofund
intergovernment
organ
studi
properli
declar
sourc
fund
studi
except
two
model
base
adopt
either
dynam
static
approach
wherea
one
studi
compar
approach
one
paper
clearli
state
approach
use
time
horizon
time
window
patient
follow
resourc
use
health
cost
outcom
measur
vari
larg
across
studi
rang
one
month
lifetim
studi
clearli
state
time
horizon
employ
tabl
tabl
compar
qualiti
evid
use
econom
evalu
conduct
pandem
illustr
poor
qualiti
data
use
baselin
clinic
data
estim
advers
event
complic
intervent
resourc
use
util
studi
conduct
half
inform
nonanalyt
studi
eg
case
report
case
seri
expert
opinion
unsourc
inform
signific
improv
observ
econom
evalu
conduct
event
studi
major
baselin
clinic
data
obtain
case
seri
analys
reliabl
administr
databas
set
interest
almost
half
studi
employ
resourc
use
inform
reliabl
administr
data
set
set
interest
also
half
util
deriv
direct
indirect
util
assess
rather
unknown
sourc
expert
opinion
nevertheless
much
differ
qualiti
clinic
effect
size
paramet
studi
may
explain
fact
appropri
clinic
effect
size
sourc
random
control
trial
pandem
event
unrel
avail
type
studi
figur
compar
cost
per
qali
intervent
well
pandem
evid
suggest
provid
intervent
either
gener
popul
target
group
yield
signific
influenc
icer
combin
pharmaceut
nonpharmaceut
intervent
rel
cost
effect
compar
provid
vaccin
andor
antivir
drug
pharmaceut
intervent
icer
vari
larg
cost
save
high
valu
per
qali
accord
predefin
ceil
threshold
social
distanc
strategi
nonschool
nonwork
nonhousehold
person
contact
reduc
antivir
prophylaxi
gener
popul
plu
closur
school
vaccin
gener
popul
plu
closur
school
antivir
prophylaxi
household
contact
plu
closur
school
amongst
cost
effect
strategi
low
middl
high
incom
countri
icer
well
maximum
ceil
threshold
low
incom
countri
lowest
dot
line
cours
intervent
cost
effect
low
incom
countri
also
cost
effect
countri
higher
incom
quarantin
household
contact
seem
unlik
cost
effect
even
low
middl
incom
countri
icer
well
maximum
ceil
threshold
upper
middl
incom
countri
howev
interpret
appli
high
incom
countri
depend
gni
per
capita
disappointingli
find
suggest
econom
evalu
conduct
pandem
focu
differ
intervent
compar
studi
carri
event
studi
cover
intervent
result
differ
consider
four
import
type
paramet
uncertainti
analys
found
review
tabl
epidemiolog
paramet
relat
natur
diseas
progress
infect
eg
attack
rate
reproduct
number
probabl
pandem
pandem
durat
diseas
sever
eg
case
fatal
probabl
develop
complic
relat
intervent
efficaci
coverag
stockpil
capac
time
intervent
resourc
use
cost
paramet
healthcar
cost
resourc
consum
valu
life
cost
intervent
other
util
discount
rate
studi
systemat
analyz
rel
import
paramet
sinc
studi
purpos
select
paramet
uncertainti
analysi
make
firm
conclus
paramet
import
determin
valu
money
pandem
influenza
prepared
strategi
intervent
due
import
contact
pattern
outcom
dynam
model
also
review
mode
popul
interact
consider
contact
pattern
especi
import
model
nonpharmaceut
intervent
eg
social
distanc
effect
intervent
highli
depend
popul
interact
behav
initi
phase
pandem
noteworthi
number
review
paper
provid
detail
inform
tabl
classif
studi
type
intervent
modifi
world
bank
taxonomi
contact
pattern
relev
assumpt
instead
refer
epidemiolog
studi
regard
review
relev
sourc
found
qualiti
evid
use
rang
assumpt
data
larg
studi
conduct
european
union
one
studi
conduct
pandem
appear
employ
real
data
area
affect
pandem
construct
social
network
gener
epidem
model
underli
network
mix
pattern
even
though
network
may
explicit
compartment
model
includ
review
allow
variabl
ie
assum
commun
homogen
take
account
variabl
deriv
age
sex
behavior
social
spatial
structur
although
includ
modif
allow
level
heterogen
age
specif
mix
pattern
hand
almost
half
studi
includ
agent
base
model
appear
reflect
heterogen
contact
pattern
occur
real
world
especi
social
network
design
tabl
review
identifi
fair
number
econom
evalu
prepared
strategi
intervent
influenza
pandem
especi
pandem
although
evid
remain
gener
inconclus
regard
cost
effect
intervent
pictur
chang
compar
studi
conduct
pandem
major
studi
focus
pharmaceut
intervent
use
vaccin
antivir
drug
may
explain
natur
nonpharmaceut
intervent
effect
cost
effect
difficult
assess
instanc
may
uneth
restrict
travel
introduc
public
commun
advisori
measur
specif
popul
group
lack
standard
protocol
nonpharmaceut
intervent
result
larg
variabl
practic
across
set
also
nonpharmaceut
intervent
complex
involv
multidimension
aspect
difficulti
control
confound
factor
lastli
absenc
pandem
event
difficult
introduc
radic
public
measur
eg
travel
restrict
school
closur
quarantin
hinder
opportun
gener
robust
reliabl
evid
effect
despit
larg
number
studi
pharmaceut
intervent
exist
evid
valu
money
unconvinc
sinc
differ
vaccin
drug
regimen
examin
across
select
studi
find
cost
outcom
intervent
incompar
especi
studi
conduct
pandem
howev
found
uniform
drug
regimen
prophylaxi
treatment
studi
conduct
pandem
may
explain
issu
protocol
guidelin
pandem
regard
method
econom
evalu
overal
qualiti
rel
high
may
studi
conduct
set
health
econom
well
establish
nation
methodolog
guidelin
conduct
econom
evalu
exist
set
therefor
would
affect
choic
method
employ
research
improv
compar
futur
evalu
import
introduc
intern
accept
methodolog
guidelin
although
guid
standardis
econom
evalu
immun
programm
publicli
avail
applic
vaccin
antivir
drug
nonpharmaceut
intervent
figur
present
novel
approach
summar
cost
effect
evid
across
intervent
target
popul
use
decis
maker
countri
also
intergovernment
organ
guid
support
countri
alloc
resourc
unit
nation
children
fund
unicef
world
bank
howev
interpret
result
figur
need
done
caution
synthesi
domin
three
studi
although
data
studi
use
author
paper
assess
wide
rang
pharmaceut
nonpharmaceut
intervent
met
elig
criterion
includ
figur
ie
present
result
term
increment
cost
util
ratio
tabl
apart
recogn
challeng
conduct
systemat
review
econom
evalu
synthes
studi
present
cost
util
ratio
shown
figur
due
pauciti
data
regardless
qualiti
evid
methodolog
use
howev
significantli
affect
result
sinc
overal
qualiti
input
evid
econom
evalu
method
similar
across
studi
addit
despit
effort
provid
inform
cost
effect
intervent
develop
countri
use
world
bank
threshold
transfer
cost
outcom
across
jurisdict
remain
controversi
issu
comparison
work
postma
review
econom
evalu
influenza
pandem
intervent
medlin
sole
sourc
review
comprehens
postma
provid
descript
result
review
methodolog
recommend
futur
econom
evalu
whilst
review
focu
examin
methodolog
approach
aim
offer
polici
recommend
fulli
succeed
due
limit
review
studi
includ
pauciti
effect
cost
effect
studi
nonpharmaceut
intervent
limit
number
studi
assess
valu
money
across
intervent
strengthen
evid
base
prepared
strategi
intervent
influenza
pandem
four
major
recommend
firstli
research
encourag
facilit
effect
cost
effect
intervent
influenza
pandem
especi
develop
countri
addit
new
accept
guidelin
econom
evalu
intervent
develop
complement
exist
guidelin
secondli
recommend
futur
econom
evalu
appli
transpar
systemat
approach
analyz
uncertainti
surround
input
paramet
achiev
use
valu
inform
approach
name
expect
valu
perfect
inform
paramet
techniqu
estim
valu
reduc
uncertainti
around
particular
paramet
model
techniqu
rare
use
review
studi
final
pandem
rare
unforese
event
global
commun
readi
next
event
measur
consequ
influenza
pandem
relat
intervent
guidelin
prepared
influenza
pandem
also
assess
impact
systemat
reliabl
manner
strongli
warrant
tabl
search
perform
electron
sourc
inform
doc
